Blood glucose meter
Latest Roche Diabetes Care, Inc. Patents:
- Method of determining a concentration of an analyte in a bodily fluid
- Method and devices for performing an analytical measurement
- Method and system for determining concentration of an analyte in a sample of a bodily fluid, and method and system for generating a software-implemented module
- AUTONOMOUS MANAGEMENT OF A DIABETIC CONDITION BASED ON MEALTIME AND ACTIVITY DETECTION
- Dual action door mechanism for a battery compartment
Description
The broken lines represent the bounds of the claim and form no part of the claimed design.
Claims
The ornamental design for a blood glucose meter, as shown and described.
Referenced Cited
U.S. Patent Documents
Other references
D406895 | March 16, 1999 | Byrd et al. |
D548347 | August 7, 2007 | Ichino |
D611853 | March 16, 2010 | Salter et al. |
D628915 | December 14, 2010 | Faulkner |
D646787 | October 11, 2011 | Presta et al. |
D648029 | November 1, 2011 | Presta et al. |
D713963 | September 23, 2014 | Liedtke |
D721177 | January 13, 2015 | Ahlstrom et al. |
D721178 | January 13, 2015 | Harkin et al. |
D737980 | September 1, 2015 | Golnik |
20100113896 | May 6, 2010 | Cadio et al. |
- Accu-Chek® Advantage Meter System, www.accu-chek.com/us/glucose-meters/advantage.html (printed therefrom on Apr. 15, 2014).
- Accu-Chek® Aviva Plus System, www.accu-chek.com/us/glucose-meters/aviva.html (printed therefrom on Apr. 15, 2014).
- Accu-Chek® Compact Plus Meter System, www.accu-chek.com/us/glucose-meters/compact-plus.html (printed therefrom on Apr. 15, 2014).
- Accu-Chek® Nano Meter, www.accu-chek.com/us/glucose-meters/nano.html (printed therefrom on Apr. 15, 2014).
- Design U.S. Appl. No. 29/490,205, filed May 7, 2014 to Roche Diagnostics Operations, Inc.
Patent History
Patent number: D778445
Type: Grant
Filed: Aug 20, 2015
Date of Patent: Feb 7, 2017
Assignee: Roche Diabetes Care, Inc. (Indianapolis, IN)
Inventors: Michel A. Cadio (Carmel, IN), Thomas Z. Harkin (Bristol), David C. Krey (Heidelberg), Sebastian Liedtke (Heidelberg), Jessica Wiedemann (Lampertheim)
Primary Examiner: Anhdao Doan
Application Number: 29/536,902
Type: Grant
Filed: Aug 20, 2015
Date of Patent: Feb 7, 2017
Assignee: Roche Diabetes Care, Inc. (Indianapolis, IN)
Inventors: Michel A. Cadio (Carmel, IN), Thomas Z. Harkin (Bristol), David C. Krey (Heidelberg), Sebastian Liedtke (Heidelberg), Jessica Wiedemann (Lampertheim)
Primary Examiner: Anhdao Doan
Application Number: 29/536,902
Classifications
Current U.S. Class:
Hematological Or Intravenous Treatment (41) (D24/169)